Tudor Investment Corp ET AL Takes $740,000 Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Tudor Investment Corp ET AL acquired a new stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 34,954 shares of the company's stock, valued at approximately $740,000.

Several other institutional investors have also modified their holdings of the stock. American Century Companies Inc. lifted its stake in Surgery Partners by 223.9% in the fourth quarter. American Century Companies Inc. now owns 1,399,756 shares of the company's stock worth $29,633,000 after purchasing an additional 967,534 shares during the last quarter. Norges Bank purchased a new stake in shares of Surgery Partners in the fourth quarter worth approximately $15,796,000. Dimensional Fund Advisors LP lifted its stake in shares of Surgery Partners by 18.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company's stock worth $75,739,000 after acquiring an additional 563,812 shares during the last quarter. Raymond James Financial Inc. purchased a new position in Surgery Partners during the 4th quarter valued at $10,130,000. Finally, E. Ohman J or Asset Management AB boosted its holdings in Surgery Partners by 40.3% during the 4th quarter. E. Ohman J or Asset Management AB now owns 1,243,111 shares of the company's stock valued at $26,317,000 after acquiring an additional 357,023 shares during the period.

Wall Street Analysts Forecast Growth

SGRY has been the subject of several research analyst reports. Royal Bank of Canada reiterated an "outperform" rating and set a $35.00 target price on shares of Surgery Partners in a research report on Tuesday, March 25th. Macquarie decreased their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a report on Tuesday, March 11th. Finally, Benchmark reaffirmed a "buy" rating and set a $35.00 price target on shares of Surgery Partners in a research note on Monday, April 21st. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $34.75.

Insider Buying and Selling at Surgery Partners

In related news, insider Marissa Brittenham sold 3,156 shares of the firm's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the completion of the transaction, the insider now owns 63,408 shares in the company, valued at $1,527,498.72. This trade represents a 4.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO David T. Doherty sold 6,733 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now owns 150,868 shares in the company, valued at approximately $3,623,849.36. The trade was a 4.27% decrease in their position. The disclosure for this sale can be found here. 2.30% of the stock is owned by insiders.

Surgery Partners Stock Down 1.0%

Shares of NASDAQ SGRY traded down $0.23 during mid-day trading on Tuesday, reaching $23.03. 242,715 shares of the company were exchanged, compared to its average volume of 1,086,800. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $33.97. The firm has a 50-day moving average of $22.60 and a 200 day moving average of $23.32. The stock has a market cap of $2.95 billion, a price-to-earnings ratio of -47.98, a P/E/G ratio of 19.21 and a beta of 1.96. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.04). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $776.00 million for the quarter, compared to analysts' expectations of $777.77 million. During the same period in the previous year, the company posted $0.10 earnings per share. The business's quarterly revenue was up 8.2% compared to the same quarter last year. On average, research analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.